Are there clinical trials for diffuse large b cell lymphoma relapsed?

Yes. Clin2 currently lists 219 recruiting diffuse large b cell lymphoma relapsed studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.

How do I know if I qualify for a diffuse large b cell lymphoma relapsed trial?

Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Does it cost anything to join a diffuse large b cell lymphoma relapsed trial?

Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.

Clinical trials

Diffuse Large B Cell Lymphoma Relapsed clinical trials

Below are recruiting diffuse large b cell lymphoma relapsed clinical trials, each written for real people, not researchers. We’re tracking 219 recruiting studies, each written for real people, not researchers, below.

Search diffuse large b cell lymphoma relapsed trials near you

Recruiting studies

NCT06453044RecruitingPhase 2
Study of two drugs for follicular lymphoma that came back
This study tests a combination of two targeted drugs (mosunetuzumab and polatuzumab vedotin) for people with follicular lymphoma that has come back or not responded to previous treatment. The goal is to see if this two-drug approach can help shrink tumors and control the disease.
Duarte, CaliforniaAges 18 years+
NCT07234110Recruiting
CD5 CAR-T therapy for returning blood cancers
This trial tests a new treatment using your own immune cells, modified to find and attack cancer cells that have a CD5 marker. It may be an option for people with certain lymphomas or leukemia that have not responded to standard treatments or have come back.
Tianjin, Tianjin MunicipalityAges 1–70
NCT06013423RecruitingPhase 2
Cord blood transplant with chemo and radiation for high-risk blood cancers
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
Seattle, WashingtonAges 6 months–65 years

Hear when a new Diffuse Large B Cell Lymphoma Relapsed trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.

Common questions

Are there clinical trials for diffuse large b cell lymphoma relapsed?: Yes. Clin2 currently lists 219 recruiting diffuse large b cell lymphoma relapsed studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
How do I know if I qualify for a diffuse large b cell lymphoma relapsed trial?: Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Does it cost anything to join a diffuse large b cell lymphoma relapsed trial?: Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.

Related conditions

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.

Recruiting studies

Study of two drugs for follicular lymphoma that came back

CD5 CAR-T therapy for returning blood cancers

Cord blood transplant with chemo and radiation for high-risk blood cancers

Common questions

Related conditions